Efficacy of Moderna, Pfizer and Johnson & Johnson COVID-19 Vaccines Against the Omicron Variant
Read synopses of how each vaccine fares against the Omicron variant according to the latest data:
Read More »
Boosters
FDA Authorizes Pfizer Booster for Young Adults
Yesterday, the FDA authorized COVID-19 booster shots for 16 and 17 year olds. Young adults in this age group who’ve received two shots of the Pfizer vaccine may now receive a third dose, 6 months after their primary series.
Read More »CDC expands eligibility of boosters for 18+
Last Friday, the CDC expanded booster eligibility for everyone over 18 years of age. Those who received a Pfizer or Moderna vaccine may now receive a booster dose 6 months after their primary series.
Read More »FDA Authorizes Pfizer and Moderna Boosters for 18+
This morning, the FDA expanded eligibility around booster shots of both the Pfizer and Moderna vaccines for adults 18+, six months after their primary series. Those who have received a Johnson & Johnson vaccine for their primary series can receive a Pfizer or Moderna booster dose two months after their single dose primary series
Read More »